# UW-CTRI Triple Medication Smoking Cessation Study

> **NCT02681510** · PHASE4 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 36 (actual)

## Conditions studied

- Smoking

## Interventions

- **DRUG:** Varenicline
- **DRUG:** Nicotine Transdermal Patch
- **DRUG:** Nicotine Mini

## Key facts

- **NCT ID:** NCT02681510
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2016-06-13
- **Final completion:** 2016-06-13
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2017-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02681510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02681510, "UW-CTRI Triple Medication Smoking Cessation Study". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02681510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*